Angiotensin-Converting Enzyme Inhibitor Associated Cough: Deceptive Information from the Physicians' Desk Reference
- 30 November 2010
- journal article
- research article
- Published by Elsevier BV in The American Journal of Medicine
- Vol. 123 (11), 1016-1030
- https://doi.org/10.1016/j.amjmed.2010.06.014
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- FDA Drug Information That Never Reaches CliniciansThe New England Journal of Medicine, 2010
- Misdiagnosis and mistreatment of a common side‐effect – angiotensin‐converting enzyme inhibitor‐induced coughBritish Journal of Clinical Pharmacology, 2010
- Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertensionThe American Journal of Cardiology, 2004
- A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: The MAPAVEL studyClinical Therapeutics, 2002
- Differential effects of fosinopril and enalapril in patients with mild to moderate chronic heart failureAmerican Heart Journal, 1998
- Nebivolol vs enalapril in the treatment of essential hypertension: a double-blind randomised trialJournal of Human Hypertension, 1997
- Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD)American Heart Journal, 1996
- Comparison of lisinopril versus digoxin for congestive heart failure during maintenance diuretic therapyThe American Journal of Cardiology, 1992
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureThe New England Journal of Medicine, 1987
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986